Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Elderly Woman Killed in Pedestrian Crash at Avalon Boulevard and 184th Street


Victim Hit by Vehicle in Fatal San Diego Accident 

Carson, CA (March 16, 2020) – An elderly woman was killed in a pedestrian crash in Carson. The fatal accident occurred on the evening of March 16 at Avalon Boulevard and 184th Street.

An 86-year-old woman was outside of a crosswalk when she attempted to cross Avalon Boulevard. A vehicle hit the woman and she died at the accident scene. The driver of the vehicle remained at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Carson

#90746


December 10, 2019

Man Killed, 3 Injured in Crash on Highway 101 Near Todd Road

Driver Loses Control, Hits Tree in Fatal Santa Rosa Accident...


March 2, 2020

2 Killed, 3 Injured in Crash on State Route 145

Both Drivers Die in Head on Accident in Madera Ranchos...


November 19, 2019

Child Killed, 2 Injured in Crash on Pico Canyon Road

Woman Hits Electrical Pole, Tree in Fatal Stevenson Ranch Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.